Matt Miksic
Stock Analyst at Barclays
(3.27)
# 2,442
Out of 4,517 analysts
807
Total ratings
50.7%
Success rate
1.9%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintained: Buy | $96 → $89 | $44.62 | +99.46% | 50 | May 28, 2026 | |
| PODD Insulet | Maintained: Sell | $198 | $164.43 | +20.42% | 20 | May 28, 2026 | |
| DXCM DexCom | Rated: Sell | $67 → $64 | $77.98 | -17.93% | 22 | May 18, 2026 | |
| AVR Anteris Technologies Global | Maintained: Buy | $17 → $18 | $8.34 | +115.83% | 6 | May 15, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Hold | $255 | $249.97 | +2.01% | 93 | May 13, 2026 | |
| OBIO Orchestra BioMed Holdings | Rated: Buy | $12 → $13 | $3.72 | +249.46% | 7 | May 13, 2026 | |
| HUMA Humacyte | Rated: Buy | $1.5 | $0.6596 | +127.41% | 4 | May 13, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $202 → $204 | $159.93 | +27.56% | 23 | May 11, 2026 | |
| GMED Globus Medical | Maintained: Buy | $123 | $80.91 | +52.02% | 49 | May 11, 2026 | |
| SENS Senseonics Holdings | Maintained: Buy | $31 | $5.14 | +503.11% | 7 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $55 | $16.29 | +237.63% | 19 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $76 | $81.79 | -7.08% | 21 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $15.60 | +21.83% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $24 | $9.27 | +158.90% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 72.76 → CHF 63.06 | CHF 56.94 | +10.75% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $27 | $23.35 | +15.63% | 41 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $469 → $394 | $331.20 | +18.96% | 48 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $16.81 | +18.98% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 → $78 | $65.70 | +18.72% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 → $94 | $93.75 | +0.27% | 40 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $110 | $87.84 | +25.23% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $712 → $651 | $402.33 | +61.81% | 19 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $144 → $143 | $98.83 | +44.69% | 50 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 → $120 | $83.56 | +43.61% | 68 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $15.88 | +63.73% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $103 | $73.10 | +40.90% | 6 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.67 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $722 → $418 | $178.41 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $13 | $0.15 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $28 | $18.27 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $67 | $13.85 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $88.26 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $79 → $87 | $19.85 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $26.99 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $4.43 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $2.19 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 | $31.41 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $6.94 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $45.01 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $11.89 | n/a | 3 | Mar 14, 2013 |
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $96 → $89
Current: $44.62
Upside: +99.46%
Insulet
May 28, 2026
Maintained: Sell
Price Target: $198
Current: $164.43
Upside: +20.42%
DexCom
May 18, 2026
Rated: Sell
Price Target: $67 → $64
Current: $77.98
Upside: -17.93%
Anteris Technologies Global
May 15, 2026
Maintained: Buy
Price Target: $17 → $18
Current: $8.34
Upside: +115.83%
Johnson & Johnson
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $249.97
Upside: +2.01%
Orchestra BioMed Holdings
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $3.72
Upside: +249.46%
Humacyte
May 13, 2026
Rated: Buy
Price Target: $1.5
Current: $0.6596
Upside: +127.41%
Becton, Dickinson and Company
May 11, 2026
Rated: Buy
Price Target: $202 → $204
Current: $159.93
Upside: +27.56%
Globus Medical
May 11, 2026
Maintained: Buy
Price Target: $123
Current: $80.91
Upside: +52.02%
Senseonics Holdings
May 11, 2026
Maintained: Buy
Price Target: $31
Current: $5.14
Upside: +503.11%
May 8, 2026
Maintained: Buy
Price Target: $56 → $55
Current: $16.29
Upside: +237.63%
May 7, 2026
Maintained: Hold
Price Target: $73 → $76
Current: $81.79
Upside: -7.08%
May 7, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $15.60
Upside: +21.83%
May 6, 2026
Maintained: Buy
Price Target: $27 → $24
Current: $9.27
Upside: +158.90%
May 6, 2026
Reiterated: Hold
Price Target: CHF 72.76 → CHF 63.06
Current: CHF 56.94
Upside: +10.75%
May 4, 2026
Maintained: Buy
Price Target: $25 → $27
Current: $23.35
Upside: +15.63%
May 1, 2026
Maintained: Buy
Price Target: $469 → $394
Current: $331.20
Upside: +18.96%
Apr 30, 2026
Maintained: Hold
Price Target: $20
Current: $16.81
Upside: +18.98%
Apr 30, 2026
Maintained: Hold
Price Target: $87 → $78
Current: $65.70
Upside: +18.72%
Apr 29, 2026
Maintained: Sell
Price Target: $100 → $94
Current: $93.75
Upside: +0.27%
Apr 24, 2026
Maintained: Buy
Price Target: $104 → $110
Current: $87.84
Upside: +25.23%
Apr 23, 2026
Rated: Buy
Price Target: $712 → $651
Current: $402.33
Upside: +61.81%
Apr 20, 2026
Rated: Buy
Price Target: $144 → $143
Current: $98.83
Upside: +44.69%
Apr 1, 2026
Maintained: Buy
Price Target: $118 → $120
Current: $83.56
Upside: +43.61%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $15.88
Upside: +63.73%
Mar 24, 2026
Reiterated: Buy
Price Target: $103
Current: $73.10
Upside: +40.90%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $2.67
Upside: n/a
May 4, 2022
Maintained: Buy
Price Target: $722 → $418
Current: $178.41
Upside: n/a
Mar 4, 2022
Maintained: Buy
Price Target: $16 → $13
Current: $0.15
Upside: n/a
Mar 2, 2022
Maintained: Buy
Price Target: $31 → $28
Current: $18.27
Upside: n/a
Mar 1, 2022
Maintained: Buy
Price Target: $74 → $67
Current: $13.85
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $100
Current: $88.26
Upside: n/a
Nov 3, 2021
Maintained: Buy
Price Target: $79 → $87
Current: $19.85
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $26.99
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $4.43
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $2.19
Upside: n/a
Nov 3, 2014
Maintained: Hold
Price Target: $37
Current: $31.41
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $6.94
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $45.01
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $11.89
Upside: n/a